Literature DB >> 9311047

The value of a risk factor analysis in clinically suspected deep venous thrombosis.

E Oger1, C Leroyer, E Le Moigne, M P Pomey, L Bressollette, J Clavier, D Mottier.   

Abstract

BACKGROUND: The value of a risk factor analysis in the presence of a clinically suspected deep venous thrombosis (DVT) has been assessed mainly in inpatient populations. The aim of this prospective study was to evaluate the potential association between DVT and acquired circumstances suspected as risk factors, in a cohort of outpatients with a clinically suspected DVT.
METHODS: Consecutive outpatients referred for a clinically suspected DVT, with recent clinical signs, not exceeding 1 week, were included. Before venography, all patients were interviewed by a trained physician to detect the presence of risk factors.
RESULTS: From March 1992 to February 1994, 277 patients were included; venography was positive in 162 (58.4%). Five independent variables were significantly associated with the occurrence of DVT; in a multivariate analysis, 64.7% of patients were correctly classified; odds ratios for having DVT in the presence of these underlying conditions were respectively: 1.75 for age over 65 years, 1.68 for prior history of venous thromboembolism, 1.69 for high risk circumstances (any type of surgery or leg trauma within the past 3 months), 5.59 for malignancy, and 2.56 for varicose veins.
CONCLUSIONS: In outpatients referred for a clinically suspected DVT, recognition of associated conditions might increase the certainty of the diagnosis.

Entities:  

Mesh:

Year:  1997        PMID: 9311047     DOI: 10.1159/000196699

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  7 in total

Review 1.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

2.  The Prophylaxis of Venous Thromboembolism.

Authors:  Albrecht Encke; Sylvia Haas; Ina Kopp
Journal:  Dtsch Arztebl Int       Date:  2016-08-08       Impact factor: 5.594

3.  Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.

Authors:  Russell D Hull; Sebastian M Schellong; Victor F Tapson; Manuel Monreal; Meyer-Michel Samama; Alexander G G Turpie; Peter Wildgoose; Roger D Yusen
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

4.  The incidence of venous thromboembolism following stroke and its risk factors in eastern China.

Authors:  Xingyang Yi; Jing Lin; Zhao Han; Xudong Zhou; Xiaotong Wang; Jiguang Lin
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

5.  Deep vein thrombosis in medical and surgical Intensive Care Unit patients in a Tertiary Care Centre in North India: Incidence and risk factors.

Authors:  Ashish Kumar; Yatin Mehta; Tariq Ali; Mukesh Kumar Gupta; Joby V George
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Apr-Jun

Review 6.  Influence of acquired and genetic risk factors on the prevention, management, and treatment of thromboembolic disease.

Authors:  Raghid Kreidy
Journal:  Int J Vasc Med       Date:  2014-06-26

7.  High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma.

Authors:  Xi Zhang; Jia-Jia Huang; Yi Xia; Chao-Feng Li; Yu Wang; Pan-Pan Liu; Xi-Wen Bi; Peng Sun; Tong-Yu Lin; Wen-Qi Jiang; Zhi-Ming Li
Journal:  Oncotarget       Date:  2016-06-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.